MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review

The alterations of MET have been detected in non-small-cell lung cancer (NSCLC). However, survival benefit of MET inhibitors remains controversial. We performed this meta-analysis to evaluate the survival benefit of MET inhibitors combined with an epidermal growth factor receptor tyrosine kinase inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Han, Kim, Hyeong Su, Kim, Bum Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650440/
https://www.ncbi.nlm.nih.gov/pubmed/29088885
http://dx.doi.org/10.18632/oncotarget.20824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650440/
https://www.ncbi.nlm.nih.gov/pubmed/29088885
http://dx.doi.org/10.18632/oncotarget.20824

Ejemplares similares